Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | VIR |
---|---|---|
09:32 ET | 12355 | 9.4073 |
09:33 ET | 3361 | 9.5555 |
09:37 ET | 1393 | 9.48 |
09:39 ET | 909 | 9.42 |
09:42 ET | 2572 | 9.4 |
09:44 ET | 9787 | 9.39 |
09:50 ET | 6329 | 9.35 |
09:51 ET | 700 | 9.44 |
09:53 ET | 798 | 9.46 |
09:55 ET | 2290 | 9.46 |
09:57 ET | 300 | 9.4 |
10:00 ET | 1100 | 9.39 |
10:02 ET | 1129 | 9.4 |
10:04 ET | 2200 | 9.34 |
10:06 ET | 500 | 9.35 |
10:08 ET | 550 | 9.3474 |
10:09 ET | 1607 | 9.3 |
10:11 ET | 300 | 9.29 |
10:13 ET | 2175 | 9.29 |
10:15 ET | 699 | 9.3 |
10:18 ET | 1000 | 9.34 |
10:20 ET | 1171 | 9.36 |
10:22 ET | 1612 | 9.38 |
10:24 ET | 200 | 9.39 |
10:26 ET | 1955 | 9.4 |
10:27 ET | 1949 | 9.41 |
10:29 ET | 1347 | 9.44 |
10:31 ET | 200 | 9.44 |
10:33 ET | 2570 | 9.45 |
10:36 ET | 281 | 9.449 |
10:38 ET | 1299 | 9.48 |
10:40 ET | 1929 | 9.51 |
10:42 ET | 4702 | 9.4726 |
10:45 ET | 280 | 9.4799 |
10:47 ET | 3096 | 9.43 |
10:49 ET | 2100 | 9.415 |
10:51 ET | 568 | 9.43 |
10:54 ET | 914 | 9.465 |
10:56 ET | 247 | 9.465 |
10:58 ET | 1224 | 9.52 |
11:00 ET | 1505 | 9.52 |
11:02 ET | 942 | 9.51 |
11:03 ET | 2605 | 9.49 |
11:05 ET | 4029 | 9.51 |
11:07 ET | 2349 | 9.46 |
11:09 ET | 300 | 9.47 |
11:12 ET | 1306 | 9.49 |
11:14 ET | 900 | 9.49 |
11:16 ET | 3117 | 9.44 |
11:18 ET | 925 | 9.43 |
11:20 ET | 4550 | 9.42 |
11:21 ET | 860 | 9.46 |
11:23 ET | 100 | 9.46 |
11:25 ET | 830 | 9.45 |
11:27 ET | 2157 | 9.46 |
11:30 ET | 1213 | 9.475 |
11:32 ET | 2229 | 9.51 |
11:34 ET | 1004 | 9.49 |
11:36 ET | 195 | 9.51 |
11:38 ET | 2013 | 9.505 |
11:39 ET | 1753 | 9.51 |
11:41 ET | 439 | 9.51 |
11:43 ET | 3100 | 9.47 |
11:45 ET | 1681 | 9.48 |
11:48 ET | 1053 | 9.5 |
11:50 ET | 1246 | 9.5 |
11:52 ET | 2453 | 9.47 |
11:54 ET | 100 | 9.48 |
11:56 ET | 800 | 9.49 |
11:57 ET | 463 | 9.48 |
11:59 ET | 744 | 9.48 |
12:01 ET | 600 | 9.475 |
12:03 ET | 1404 | 9.46 |
12:06 ET | 2040 | 9.47 |
12:08 ET | 162 | 9.47 |
12:10 ET | 200 | 9.45 |
12:12 ET | 700 | 9.455 |
12:14 ET | 2044 | 9.47 |
12:15 ET | 100 | 9.46 |
12:17 ET | 2107 | 9.465 |
12:19 ET | 2285 | 9.46 |
12:21 ET | 5576 | 9.48 |
12:24 ET | 100 | 9.49 |
12:26 ET | 300 | 9.485 |
12:28 ET | 2506 | 9.47 |
12:30 ET | 5043 | 9.42 |
12:32 ET | 1300 | 9.41 |
12:33 ET | 775 | 9.39 |
12:35 ET | 200 | 9.39 |
12:37 ET | 3343 | 9.43 |
12:39 ET | 200 | 9.46 |
12:44 ET | 1955 | 9.46 |
12:46 ET | 1034 | 9.46 |
12:48 ET | 2390 | 9.48 |
12:50 ET | 200 | 9.49 |
12:51 ET | 1502 | 9.48 |
12:53 ET | 1118 | 9.465 |
12:55 ET | 1005 | 9.45 |
12:57 ET | 409 | 9.46 |
01:00 ET | 200 | 9.47 |
01:02 ET | 500 | 9.47 |
01:04 ET | 5929 | 9.51 |
01:06 ET | 3548 | 9.48 |
01:08 ET | 200 | 9.51 |
01:09 ET | 355 | 9.49 |
01:11 ET | 5734 | 9.51 |
01:13 ET | 100 | 9.53 |
01:15 ET | 2832 | 9.495 |
01:20 ET | 200 | 9.5 |
01:22 ET | 200 | 9.5 |
01:24 ET | 500 | 9.49 |
01:26 ET | 808 | 9.5 |
01:27 ET | 9718 | 9.53 |
01:29 ET | 100 | 9.53 |
01:31 ET | 100 | 9.52 |
01:33 ET | 4087 | 9.51 |
01:36 ET | 2519 | 9.4983 |
01:38 ET | 1101 | 9.5 |
01:40 ET | 1200 | 9.5 |
01:44 ET | 400 | 9.5 |
01:45 ET | 3798 | 9.54 |
01:47 ET | 100 | 9.542 |
01:49 ET | 3475 | 9.535 |
01:51 ET | 300 | 9.54 |
01:54 ET | 554 | 9.54 |
01:56 ET | 100 | 9.54 |
01:58 ET | 758 | 9.535 |
02:00 ET | 1100 | 9.52 |
02:02 ET | 4613 | 9.505 |
02:03 ET | 1002 | 9.495 |
02:05 ET | 800 | 9.51 |
02:07 ET | 1783 | 9.51 |
02:09 ET | 200 | 9.51 |
02:12 ET | 354 | 9.5 |
02:14 ET | 200 | 9.51 |
02:16 ET | 350 | 9.51 |
02:18 ET | 400 | 9.51 |
02:20 ET | 4721 | 9.52 |
02:21 ET | 3500 | 9.54 |
02:23 ET | 2225 | 9.54 |
02:25 ET | 411 | 9.54 |
02:27 ET | 3099 | 9.515 |
02:30 ET | 3469 | 9.515 |
02:32 ET | 5254 | 9.5 |
02:34 ET | 1350 | 9.5 |
02:36 ET | 100 | 9.505 |
02:38 ET | 2168 | 9.515 |
02:39 ET | 1388 | 9.515 |
02:41 ET | 3135 | 9.53 |
02:43 ET | 1077 | 9.515 |
02:45 ET | 896 | 9.495 |
02:48 ET | 729 | 9.5 |
02:50 ET | 100 | 9.495 |
02:52 ET | 400 | 9.495 |
02:54 ET | 528 | 9.49 |
02:56 ET | 100 | 9.49 |
02:57 ET | 1986 | 9.485 |
02:59 ET | 1427 | 9.485 |
03:01 ET | 4865 | 9.495 |
03:03 ET | 9663 | 9.495 |
03:06 ET | 453 | 9.495 |
03:08 ET | 2447 | 9.505 |
03:10 ET | 1000 | 9.505 |
03:12 ET | 766 | 9.505 |
03:14 ET | 12817 | 9.475 |
03:15 ET | 4275 | 9.505 |
03:19 ET | 419 | 9.505 |
03:21 ET | 600 | 9.505 |
03:24 ET | 1364 | 9.5012 |
03:26 ET | 1722 | 9.49 |
03:28 ET | 500 | 9.495 |
03:30 ET | 3939 | 9.525 |
03:32 ET | 4644 | 9.54 |
03:33 ET | 4805 | 9.535 |
03:35 ET | 2514 | 9.545 |
03:37 ET | 5846 | 9.535 |
03:39 ET | 1058 | 9.53 |
03:42 ET | 2713 | 9.53 |
03:44 ET | 1035 | 9.525 |
03:46 ET | 5650 | 9.525 |
03:48 ET | 3502 | 9.545 |
03:50 ET | 4321 | 9.55 |
03:51 ET | 18688 | 9.555 |
03:53 ET | 9133 | 9.555 |
03:55 ET | 26204 | 9.585 |
03:57 ET | 22899 | 9.59 |
04:00 ET | 282812 | 9.59 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Vir Biotechnology Inc | 1.3B | -2.1x | --- |
Sinovac Biotech Ltd | 639.9M | -1.8x | +15.89% |
Novavax Inc | 662.8M | -0.9x | --- |
Maravai LifeSciences Holdings Inc | 1.3B | 11.0x | --- |
P3 Health Partners Inc | 360.1M | -0.4x | --- |
Dynavax Technologies Corp | 1.7B | 36.4x | --- |
Vir Biotechnology, Inc. is an immunology company, which is focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions. The Company has assembled two technology platforms that are designed to stimulate and enhance the immune system by exploiting critical observations of natural immune processes. Its clinical development pipeline consists of product candidates targeting hepatitis B virus (HBV), hepatitis delta virus (HDV) and human immunodeficiency virus (HIV). The Company also has several preclinical candidates in its pipeline including those targeting influenza A and B, COVID-19, respiratory syncytial virus and human metapneumovirus (RSV and MPV), and human papillomavirus (HPV). Its pipeline includes VIR-2218, VIR-3434, VIR-1388, VIR-7229, VIR-2482, VIR-2981, VIR-8190, and VIR-1949. VIR-2218 is an investigational HBV-targeting siRNA. VIR-1388 is an investigational HIV T cell vaccine based on human cytomegalovirus (HCMV).
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.3B |
---|---|
Revenue (TTM) | $118.8M |
Shares Outstanding | 134.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.38 |
EPS | $-4.49 |
Book Value | $15.60 |
P/E Ratio | -2.1x |
Price/Sales (TTM) | 10.7 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -585.67% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.